Impact of ventricular tachycardia ablation in subcutaneous implantable cardioverter defibrillator carriers: a multicentre, international analysis from the iSUSI project.
Schiavone M, Gasperetti A, Compagnucci P, Vogler J, Laredo M, Montemerlo E, Gulletta S, Breitenstein A, Ziacchi M, Martinek M, Casella M, Palmisano P, Kaiser L, Lavalle C, Calò L, Seidl S, Saguner AM, Rovaris G, Kuschyk J, Biffi M, Di Biase L, Dello Russo A, Tondo C, Della Bella P, Tilz R, Forleo GB; iSUSI investigators.
Schiavone M, et al. Among authors: kuschyk j.
Europace. 2024 Mar 30;26(4):euae066. doi: 10.1093/europace/euae066.
Europace. 2024.
PMID: 38584394
Free PMC article.
Clinical Trial.